Exercise or conversion
Lawrence D. Kingsley
Director
Common Stock
- Value context
- $251.52K
- Reported price
- $114.17 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
IDEXX LABORATORIES INC /DE
Last 30 daysNo qualifying insider buying. Sales: $1.17M by 1 insider.
Showing the first 6 of 20 trades on this page.
Director
Common Stock
Director
Non-Qualified Stock Option (right-to-buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP, CFO and Treasurer
Common Stock
EVP, CFO and Treasurer
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
EVP, CFO and Treasurer
Incentive Stock Option (right-to-buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Executive Vice President
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Executive Vice President
Common Stock
Executive Vice President
Restricted Stock Unit
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Non-Qualified Stock Option (right-to-buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Stock Unit
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Non-Qualified Stock Option (right-to-buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Stock Unit
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Non-Qualified Stock Option (right-to-buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Stock Unit
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Non-Qualified Stock Option (right-to-buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Non-Qualified Stock Option (right-to-buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Stock Unit
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Stock Unit
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Non-Qualified Stock Option (right-to-buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockOption exercise or conversion | 2,203$114.17 / share | $251.52K | Sep 4Filed Sep 9 · 5d later | SEC filing |
| Director | Non-Qualified Stock Option (right-to-buy)Option exercise or conversion | Derivative units2,203$114.17 exercise / conversion price | Not a separate purchase | Sep 4Filed Sep 9 · 5d later | SEC filing |
| EVP, CFO and Treasurer | Common StockOption exercise or conversion | 265$178.26 / share | $47.24K | Aug 20Filed Aug 24 · 4d later | SEC filing |
| EVP, CFO and Treasurer | Common StockExercise-price or tax withholding | 86$0 reported · see filing | Not established | Aug 20Filed Aug 24 · 4d later | SEC filing |
| EVP, CFO and Treasurer | Incentive Stock Option (right-to-buy)Option exercise or conversion | Derivative units265$178.26 exercise / conversion price | Not a separate purchase | Aug 20Filed Aug 24 · 4d later | SEC filing |
| Director | Common StockGrant or award | 49$558.80 / share | $27.38K | Jul 30Filed Aug 3 · 4d later | SEC filing |
| Executive Vice President | Common StockOption exercise or conversion | 639$0 reported · see filing | Not established | Jun 1Filed Jun 2 · 1d later | SEC filing |
| Executive Vice President | Common StockExercise-price or tax withholding | 284$566.79 / share | $160.97K | Jun 1Filed Jun 2 · 1d later | SEC filing |
| Executive Vice President | Restricted Stock UnitOption exercise or conversion | Derivative units639Exercise / conversion price not reported | Not a separate purchase | Jun 1Filed Jun 2 · 1d later | SEC filing |
| Director | Non-Qualified Stock Option (right-to-buy)Grant or award | Derivative units525Award · no purchase price | Non-cash award | May 12Filed May 14 · 2d later | SEC filing |
| Director | Restricted Stock UnitGrant or award | Derivative units234Award · no purchase price | Non-cash award | May 12Filed May 14 · 2d later | SEC filing |
| Director | Non-Qualified Stock Option (right-to-buy)Grant or award | Derivative units525Award · no purchase price | Non-cash award | May 12Filed May 14 · 2d later | SEC filing |
| Director | Deferred Stock UnitGrant or award | Derivative units234Award · no purchase price | Non-cash award | May 12Filed May 14 · 2d later | SEC filing |
| Director | Non-Qualified Stock Option (right-to-buy)Grant or award | Derivative units525Award · no purchase price | Non-cash award | May 12Filed May 14 · 2d later | SEC filing |
| Director | Deferred Stock UnitGrant or award | Derivative units234Award · no purchase price | Non-cash award | May 12Filed May 14 · 2d later | SEC filing |
| Director | Non-Qualified Stock Option (right-to-buy)Grant or award | Derivative units525Award · no purchase price | Non-cash award | May 12Filed May 14 · 2d later | SEC filing |
| Director | Non-Qualified Stock Option (right-to-buy)Grant or award | Derivative units168Award · no purchase price | Non-cash award | May 12Filed May 14 · 2d later | SEC filing |
| Director | Restricted Stock UnitGrant or award | Derivative units234Award · no purchase price | Non-cash award | May 12Filed May 14 · 2d later | SEC filing |
| Director | Restricted Stock UnitGrant or award | Derivative units75Award · no purchase price | Non-cash award | May 12Filed May 14 · 2d later | SEC filing |
| Director | Non-Qualified Stock Option (right-to-buy)Grant or award | Derivative units525Award · no purchase price | Non-cash award | May 12Filed May 14 · 2d later | SEC filing |
Showing the latest 20 of 44 trades. Show all 44 trades
IDEXX Laboratories, Inc. - Common Stock (IDXX) · Stock
The filing reports a sale for a dependent.
April McClain DelaneyReporting House memberIDEXX Laboratories, Inc. - Common Stock (IDXX) · Stock
The filing reports a partial sale for a dependent.
April McClain DelaneyReporting House memberIDEXX Laboratories, Inc. - Common Stock (IDXX) · Stock
The filing reports a partial sale for a dependent.
April McClain DelaneyReporting House memberIDEXX Laboratories, Inc. - Common Stock (IDXX) · Stock
The filing reports a partial sale for a dependent.
April McClain DelaneyReporting House memberIDEXX Laboratories, Inc. - Common Stock (IDXX) · Stock
The filing reports a purchase for a spouse.
Byron DonaldsReporting House memberIDEXX Laboratories, Inc. - Common Stock (IDXX) · Stock
The filing reports a purchase for the member.
Byron DonaldsReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.